A 67-year-old man comes to the office due to pain in the lower part of his calves on his afternoon walk to get the mail. The pain is relieved by rest. It started slowly about 6 months ago and has become more painful over time. He has a history of hypertension, hyperlipidemia, diabetes mellitus, and a 20-pack-year smoking history. Medications include hydrochlorothiazide, atorvastatin, metformin, and a multivitamin that he takes daily. The patient quit smoking 2 years ago and only drinks socially. Today, his blood pressure is 145/90 mm Hg, pulse is 75/min, respiratory rate is 17/min, and temperature is 37.6°C (99.6°F). On physical exam, he appears mildly obese and healthy. His heart has a regular rate and rhythm, and his lungs are clear to auscultation bilaterally. Examination of the legs shows atrophic changes and diminished pedal pulses. A measure of his ankle brachial index (ABI) is 0.89. Which of the following is the most appropriate initial treatment?

A referral to a supervised exercise program

A recommendation to perform pedal pumping exercises

A primary care physician who focuses on treating elderly patients is researching recommendations for secondary prevention. She is particularly interested in recommendations regarding aspirin, as she has several patients who ask her if they should take it. Of the following, which patient should be started on lifelong aspirin as monotherapy for secondary prevention of atherosclerotic cardiovascular disease?

A 63-year-old male with a history of a transient ischemic attack

An 83-year-old female with a history of a hemorrhagic stroke 1 year ago without residual deficits

A 75-year-old male who had a drug-eluting coronary stent placed 3 days ago

A 67-year-old female who has diabetes mellitus and atrial fibrillation

A 45-year-old female with no health problems

A 58-year-old man comes to the physician because of a 3-month history of intermittent pain in his right calf that occurs after walking up more than 2 flights of stairs. He reports that the pain is associated with a tingling sensation and lasts for about 10 minutes. He is otherwise healthy. He has smoked 2 packs of cigarettes daily for 30 years and drinks 1 alcoholic beverage daily. He currently takes no medications. His pulse is 78/min, and blood pressure is 180/110 mm Hg. Physical examination shows yellow plaques below the lower eyelids bilaterally, loss of hair on the distal third of the right leg, and brittle toenails on the right foot. Femoral pulses are palpable bilaterally; right popliteal and pedal pulses are absent. Which of the following is the most appropriate management to prevent future morbidity and mortality of this patient's condition?

Percutaneous transluminal angioplasty

A 43-year-old woman comes to the physician because of a 3-month history of a painless ulcer on the sole of her right foot. There is no history of trauma. She has been dressing the ulcer once daily at home with gauze. She has a 15-year history of poorly-controlled type 1 diabetes mellitus and hypertension. Current medications include insulin and lisinopril. Vital signs are within normal limits. Examination shows a 2 x 2-cm ulcer on the plantar aspect of the base of the great toe with whitish, loose tissue on the floor of the ulcer and a calloused margin. A blunt metal probe reaches the deep plantar space. Sensation to vibration and light touch is decreased over both feet. Pedal pulses are intact. An x-ray of the right foot shows no abnormalities. Which of the following is the most appropriate initial step in management?

Sharp surgical debridement of the ulcer

Surgical revascularization of the right foot

Amputation of the right forefoot

Total contact casting of right foot

A 67-year-old man presents with pain in both legs. He says the pain is intermittent in nature and has been present for approximately 6 months. The pain increases with walking, especially downhill, and prolonged standing. It is relieved by lying down and leaning forward. Past medical history is significant for type 2 diabetes mellitus, hypercholesterolemia, and osteoarthritis. The patient reports a 56-pack-year history but denies any alcohol or recreational drug use. His vital signs include: blood pressure 142/88 mm Hg, pulse 88/min, respiratory rate 14/min, temperature 37°C (98.6°F). On physical examination, the patient is alert and oriented. Muscle strength is 5/5 in his upper and lower extremities bilaterally. Babinski and Romberg tests are negative. Pulses measure 2+ in upper and lower extremities bilaterally. Which of the following is the next best step in the management of this patient?

CT angiography of the lower extremities

Epidural corticosteroid injection

A 21-year-old woman comes to the physician because of a 4-day history of abdominal cramps and bloody diarrhea 5 times per day. Her symptoms began after she ate an egg sandwich from a restaurant. Her vital signs are within normal limits. Physical examination shows diffuse abdominal tenderness. Stool culture shows gram-negative rods that produce hydrogen sulfide and do not ferment lactose. Which of the following effects is most likely to occur if she receives antibiotic therapy?

Prolonged fecal excretion of the pathogen

Orange discoloration of bodily fluids

Pruritic maculopapular rash on the extensor surface

Self-limiting systemic inflammatory response

Thrombocytopenia and hemolytic anemia

Peripheral vascular disease therapies for USMLE Step 2 CK: High-Yield Pharmacology Lessons

PVD Overview - Taming the Pipes

Pathophysiology: Atherosclerosis narrows peripheral arteries, primarily in the lower extremities, leading to ↓ blood flow.
Presentation:
- Intermittent Claudication: Muscle pain/cramping with exertion, relieved by rest.
- Critical Limb Ischemia (CLI): Rest pain, non-healing ulcers, or gangrene. Requires urgent intervention.
Diagnosis:
- Ankle-Brachial Index (ABI): Key non-invasive test.
  - Normal: 1.0-1.4
  - PVD: <0.9
  - Severe: <0.4

Peripheral Artery Disease: Narrowed and Blocked Artery

⭐ Cilostazol, a phosphodiesterase inhibitor, is a key drug for symptomatic relief of claudication but is contraindicated in heart failure.

Antiplatelets & Statins - Plaque Patrol

Aspirin
- Irreversibly inhibits COX-1 & COX-2, leading to ↓ Thromboxane A₂ (TXA₂) and reduced platelet aggregation.
- Dose: 81-325 mg daily.
Clopidogrel (Plavix)
- Irreversibly blocks the P2Y₁₂ ADP receptor on platelets, preventing activation of GPIIb/IIIa receptors.
- Often used in dual antiplatelet therapy (DAPT) with aspirin, especially post-stenting.
Cilostazol
- Phosphodiesterase III inhibitor; ↑ cAMP causes vasodilation and reversible inhibition of platelet aggregation.
- Primary indication: intermittent claudication.
Statins (e.g., Atorvastatin)
- HMG-CoA reductase inhibitors.
- ↓ LDL, stabilize atherosclerotic plaques, and have pleiotropic anti-inflammatory effects.

⭐ High-Yield: Cilostazol is contraindicated in any patient with heart failure due to increased mortality risk.

Statins: Anti-atherosclerotic mechanisms

Claudication Agents - Walking Tall

Cilostazol
- Mechanism: Phosphodiesterase-3 (PDE-3) inhibitor. ↑cAMP in platelets & vascular smooth muscle.
- Effects: Potent arterial vasodilation (esp. femoral) & reversible inhibition of platelet aggregation.
- Primary use: Symptomatic management of intermittent claudication to improve walking distance.
- 📌 Cilo-STAY-zol helps you STAY on the walking trail.
Pentoxifylline
- Mechanism: A methylxanthine derivative; improves erythrocyte flexibility and decreases blood viscosity.
- Efficacy: Generally considered less effective than cilostazol; not a primary therapy.

Cilostazol: Mechanism of Action in Peripheral Artery Disease

⭐ Contraindication: Cilostazol is contraindicated in patients with heart failure of any severity due to an observed ↑mortality with other PDE-3 inhibitors in this population.

Treatment Algorithm - The Game Plan

Foundation: Lifestyle modification (smoking cessation, graded exercise) & aggressive risk factor control (statins, BP/glucose management).
Symptomatic Relief: Add specific pharmacotherapy for claudication.

Peripheral vascular disease and ischemia

⭐ Cilostazol, a phosphodiesterase inhibitor, not only improves claudication symptoms but also causes arterial vasodilation. However, it is contraindicated in heart failure due to arrhythmogenic potential.

Cilostazol, a phosphodiesterase-3 inhibitor, is a primary therapy for intermittent claudication, offering vasodilation and antiplatelet effects.

Aspirin or clopidogrel are crucial for secondary prevention of cardiovascular events in all patients with PAD.

Statins are essential to manage the underlying atherosclerosis and reduce cardiovascular risk, regardless of cholesterol levels.

ACE inhibitors or ARBs manage co-existing hypertension and may have direct vascular benefits.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play